Detection of combined hepatocellular and cholangiocarcinomas on enhanced CT: comparison with histologic findings

scientific article published in April 2005

Detection of combined hepatocellular and cholangiocarcinomas on enhanced CT: comparison with histologic findings is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2214/AJR.184.4.01841157
P698PubMed publication ID15788587
P5875ResearchGate publication ID7946484

P50authorTsuyoshi TajimaQ88015638
Yoshiki AsayamaQ88575700
H HondaQ88632968
Akihiro NishieQ89914901
Kenji ShinozakiQ90748176
Kengo YoshimitsuQ92455532
Hiroyuki IrieQ114021196
Mitsuo ShimadaQ114289696
Tomohiro NakayamaQ116781293
Daisuke KakiharaQ116781294
Hitoshi AibeQ117226343
P2093author name stringShin-Ichi Aishima
Kisaku Yoshida
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectcholangiocarcinomaQ124292
P1104number of pages6
P304page(s)1157-1162
P577publication date2005-04-01
P1433published inAmerican Journal of RoentgenologyQ15752879
P1476titleDetection of combined hepatocellular and cholangiocarcinomas on enhanced CT: comparison with histologic findings
P478volume184

Reverse relations

cites work (P2860)
Q52629233A Novel Risk prediction Model for Patients with Combined Hepatocellular-Cholangiocarcinoma.
Q38465673Biphenotypic hepatic tumors: imaging findings and review of literature
Q34975197Cancer stem cells in primary liver cancers: pathological concepts and imaging findings.
Q42177616Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgery
Q40379545Combined hepatocellular and cholangiocarcinoma with sarcomatoid transformation: radiologic-pathologic correlation of a case.
Q37316850Combined hepatocellular and cholangiocellular carcinoma presenting with radiological characteristics of focal nodular hyperplasia
Q35936570Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography
Q38481613Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma: outcome after liver transplantation
Q51326232Combined hepatocellular carcinoma-cholangiocarcinoma: report of MR appearance in eleven patients.
Q53479218Combined hepatocellular cholangiocarcinoma: prognostic factors investigated by computed tomography/magnetic resonance imaging.
Q39016627Combined hepatocellular-cholangiocarcinoma: Gadoxetic acid-enhanced MRI findings correlated with pathologic features and prognosis
Q53083641Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma.
Q36732055Combined hepatocholangiocarcinoma: case-series and review of literature
Q38445643Comparison between resection and transplantation in combined hepatocellular and cholangiocarcinoma.
Q38587512Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging
Q46379419Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.
Q38723527Imaging spectrum of cholangiocarcinoma: role in diagnosis, staging, and posttreatment evaluation
Q57112805Multicenter retrospective analysis of systemic chemotherapy for unresectable combined hepatocellular and cholangiocarcinoma
Q48156461Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma
Q34823616Rapid progression of combined hepatocellular carcinoma and cholangiocarcinoma
Q38497061Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma
Q46059132The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma
Q37605862Uncommon liver tumors: Case report and literature review
Q33844564Update on Treatment Options for Advanced Bile Duct Tumours: Radioembolisation for Advanced Cholangiocarcinoma
Q48513742cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation.

Search more.